SCHEMBL7742880

SCHEMBL7742880

COC(=O)C=Cc1ccc(C(=O)N2CCN(C)CC2)cc1

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GPR183 P32249 9/20 0.60
APP P05067 1/20 0.60
KCNH2 Q12809 1/20 0.54
POLB P06746 3/20 0.54
CA12 O43570 1/20 0.53
CA1 P00915 1/20 0.53
CA2 P00918 1/20 0.53
TYR P14679 1/20 0.53
CA7 P43166 1/20 0.53
CA9 Q16790 1/20 0.53
CA14 Q9ULX7 1/20 0.53
HPGD P15428 3/20 0.52
ALOX15 P16050 1/20 0.51
GAA P10253 1/20 0.51
MAPK1 P28482 1/20 0.51
L3MBTL1 Q9Y468 1/20 0.49
MEN1 O00255 1/20 0.49
CYP1A2 P05177 1/20 0.49
CYP2D6 P10635 1/20 0.49
CYP2C19 P33261 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7742877 1.00 GPR183 (0.60) GPR183APPKCNH2POLBCA12
SCHEMBL7748548 0.84 POLB (0.59) GPR183APPKCNH2POLBHPGD
SCHEMBL7748545 0.84 POLB (0.59) GPR183APPKCNH2POLBHPGD
SCHEMBL10724841 0.78 POLB (0.81) POLBHPGDALOX15L3MBTL1MEN1
SCHEMBL64495 0.77 HPGD (0.78) GPR183POLBHPGDALOX15GAA
SCHEMBL4392112 0.77 POLB (0.65) APPPOLBHPGDALOX15L3MBTL1
SCHEMBL22579363 0.77 HDAC3 (0.60) CA12CA1CA2TYRCA7
SCHEMBL71224 0.76 CA12 (0.84) APPCA12CA1CA2TYR
SCHEMBL5057418 0.76 CA12 (0.84) APPCA12CA1CA2TYR
SCHEMBL395217 0.76 POLB (0.63) APPPOLBHPGDALOX15L3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0622361-B1 Heterocyclic compounds as bradykinin antagonists FUJISAWA PHARMACEUTICAL CO (JP) 2001-10-04 EP disclosed
US-6169095-B1 FOR PREVENTION AND/OR TREATMENT OF BRADYKININ OR ITS ANALOGUES MEDIATED DISEASES IN THE EYE, SUCH AS ALLERGY, INFLAMMATION AND PAIN OF THE EYE FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2001-01-02 US disclosed
US-5922711-A ANTIALLERGENS, ANTIINFLAMMATORY AGENTS, AUTOIMMUNE DISEASES, SHOCK OR ANALGESICS FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1999-07-13 US disclosed
US-5708173-A PREPARATION OF SUBSTITUTED QUINOLINE COMPOUNDS FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1998-01-13 US disclosed
US-5563162-A CAN BE ADMINISTERD FOR THE TREATMENT OF ALLERGY, INFLAMMATION, AUTOIMMUNE DISEASES, SHOCK OR PAIN IN ANIMALS AND HUMANS FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1996-10-08 US disclosed
EP-0622361-A1 Heterocyclic compounds as bradykinin antagonists FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1994-11-02 EP disclosed